What is already known about this subject?
Introduction
Data from the National Child Measurement Programme (NCMP) in England showed that in 2012/2013, severe obesity (Body Mass Index (BMI) ≥UK90 99.6th centile) equivalent to the adult bariatric threshold of 35kg/m 2 was found in 1.2% of girls and 1.5% of boys aged 10-11
years [1] . Severe obesity presents an increasing source of clinical and economic strain to healthcare providers.
The economic burden of obesity is substantial. In England, the costs of overweight and obesity to the health system have been calculated to be £4.2 billion per annum [2] .
Much of this burden is driven by a number of co-morbidities which occur at a higher prevalence among obese young people including type 2 diabetes, hyperlipidaemia, hypertension, sleep apnoea, as well as significant psychosocial consequences and the increased likelihood of becoming obese adults [3] [4] [5] . Thus the medical, psychological and economic consequences of obesity represent a significant challenge to healthcare systems.
Bariatric surgery is the only available intervention that results in large magnitudes of weight loss. In adults, conservative treatment of severe obesity (BMI ≥40kg/m 2 ) largely produced poor long-term results, whereas surgery for obesity usually results in significant permanent weight loss. After obesity surgery, most patients experience improved health and psychological functioning [6] with bariatric surgery considered cost-effective [7] .
Outcomes of adolescent bariatric surgery appear similar to those in adults although high quality long term data is limited. Systematic reviews suggest that surgery is highly effective for shortterm BMI reduction [8] and improves quality of life [9] . However, there is very little published data on the cost-effectiveness of bariatric surgery in adolescents, and none from the UK. In
England, National Institute for Health and Care Excellence (NICE) guidance [10] notes that bariatric surgery is not generally recommended for children and young people (Recommendation 1.10.12), but may be considered in exceptional circumstances in those who have reached psychological maturity (Recommendation 1.10.13) and have BMI ≥40kg/m 2 or BMI ≥35kg/m 2 with significant co-morbidities that would be improved if they lost weight (Recommendation 1.10.1).
We assessed the lifetime cost-effectiveness of bariatric surgery (laparoscopic Roux en Y Gastric Bypass (RYGB) or laparoscopic Sleeve Gastrectomy (SG)) compared with no intervention, using data from a cohort of 18 adolescents with severe obesity undergoing surgery in one NHS centre in the UK.
Methods

Framework of Economic Model
We conducted a cost-utility analysis using lifetime expected costs and quality-adjusted life years (QALYs) that compared bariatric surgery with no surgery.
A Markov model was used to project costs, body mass index (BMI) and QALYs over lifetime.
The Markov transition model comprised five health states such as "no co-morbidity", "diabetes", "coronary heart disease (CHD)", "stroke" and "colon cancer", and death ( Figure   1 ).
Adolescents with severe obesity (BMI ≥40kg/m 2 ) enter the model in the "no co-morbidity" health state at age of 18 years. BMI starting point for adolescents in group RYGB was 48.3kg/m 2 and for those in SG group was 60.03kg/m 2 . The model consisted of yearly cycles.
At the end of each one-year period, a proportion of the cohort can move from one health state to another or stay in the same health state. We assumed that adolescents remain in the comorbid health states until they die (age-specific death or obesity-related co-morbidity death).
The disease transition probabilities are based on disease progression related to age, gender, BMI and cycle. The model is run over 82 years (until patients are 100 years old or have died)
to estimate the lifetime costs and effects of the intervention. Costs were calculated in 2013/14 UK pounds, inflated where appropriate using the consumer price index [11] . A discount rate of 3.5% was applied for costs and effects [12] .
The higher an individual's BMI, the more likely they are to develop obesity-related comorbidities such as diabetes, CHD, stroke, sleep apnoea and some forms of cancers. Due to lack of accurate data on other risk factors, the model focused on the increased risk of developing diabetes, CHD, stroke and colon cancer, for which there are data on the risks of these conditions by BMI. However, while there are reasonable data on the risks of each individual co-morbidity and BMI, there is no data on the association between BMI and multiple combinations of these co-morbidities. Therefore, the possibility of having multiple comorbidities at the same time was not incorporated in the model. This assumption is likely to mean that we have underestimated the burden associated with obesity-related co-morbidities.
In the model, a hypothetical cohort of 1,000 adolescents with severe obesity underwent bariatric surgery (RYGB or SG) or no surgery. Effects of surgery were modelled as a reduction in BMI and consequent reduction in the development of diabetes, CHD, stroke and colon cancer. Transitions between BMI levels were modified following bariatric surgery in order to reflect the reduction in BMI observed following surgery. The initial decline in BMI due to surgery was taken from the cohort of 18 adolescents undergoing surgery at University College London Hospitals (UCLH). We then included an annual increment (obesity drift) to update an adolescent's BMI over time. Published literature shows that BMI is predicted to increase by +0.12 kg/m 2 per year in patients aged <45 years [13] , +0.07kg/m 2 per year for age between 45
and 65 years and -0.14 kg/m 2 per year for age>=65 years [14] .
Transitions into long-term co-morbidities were also modified following bariatric surgery, consistent with the benefits of bariatric surgery.
Our assumption in the no surgery group was for BMI to stay constant with no incremental drift; the assumption of no incremental drift potentially underestimates lifetime BMI in the no surgery group. However, a systematic review shows that interventions that do not include surgery generally have very limited impact on the body weight in adults with severe or morbid obesity [15] .
Parameter Estimates and Data Sources
Parameter values for the model were taken from a variety of secondary sources.
The correlation between BMI and annual risk of developing diabetes, CHD, stroke and colon cancer were calculated based on estimates from the DYNAMO-HIA project [16] . This study provides estimates of the relative risks of defined diseases according to BMI status (given as per unit increase from BMI 22=1.0; we then adjusted this estimate for the mean BMI of the adult UK population (BMI 27=1.0) [17] ). The risk of co-morbidities was adjusted according to age, gender and prevalence of diabetes, CHD and stroke based on information provided by a large representative population health survey, the 2013 Health Survey for England (HSE) [16] , complemented by published source for colon cancer [18] .
Mortality due to co-morbidities was taken from UK National Life tables 2011-2013 for diabetes, CHD, stroke and colon cancer [19] . The yearly probability of diabetes, CHD, stroke and colon cancer were obtained from the actual number of deaths [19] and disease disability Mortality rates of adolescents with severe obesity in the "no co-morbidity" health state are assumed to be equivalent to those observed in the general population. On the one hand, this may underestimate the mortality risk in this group as the mean BMI in the general population is lower than in our sample. On the other hand, the general population sample will include people with co-morbidities.
Health-Related Quality of Life
We used three published sources to estimate: (1) baseline utilities for people with obesity; (2) utilities associates with changes in BMI over time; and (3) utilities associated with each comorbidity. For (1) we used a published study that explored the relationship between BMI and health related quality of life (HRQoL), measured using the EQ-5D for men and women within a national population sample [24] . For (2) we used a published study documenting changes in utility associated with the incremental drift in BMI over time: this study reported that a oneunit decrease in BMI over 1-year period was associated with a 0.0170 gain in utility [25] . For (3) multipliers were applied to the utility weights for adolescents with co-morbidities included in the model using a catalogue of EQ-5D scores for a variety of health conditions [26] . A utility profile was constructed from age of 18 to 100 for every patient in the cohort, assigning a utility score of 0 for those who had died.
Costs
Data on resource use and costs associated with bariatric surgery were obtained from UCLH Finance Department and included the costs of the procedure (including pre-operative preparation) and the costs of 24 months of postoperative care. Costs were based on the average costs for each intervention type in the Healthcare Resource Groups (HRGs) costing system.
The direct medical costs for the surgery group were those associated with the intervention and a surgical follow-up including the pre-surgical preparation visits (up to 1 year before surgery) and follow-up costs (dietetic, physician, psychology and nursing follow-up); these were assumed until year 5 post-surgery. From year 6 post-surgery, annual medical costs related to weight control were applied, assuming one GP visit per year.
The direct medical costs for the no surgery group were assumed to be the same as those incurred pre-intervention in the surgical group, plus regular follow-up for the first year (dietetic, psychology and nursing follow-up). After 1 year, no medical costs related to weight control were applied.
The annual cost of diabetes, CHD, stroke [27] , and colon cancer [28], were obtained from published sources.
Cost-Effectiveness Analysis
The main result of the study was the incremental cost-effectiveness ratio (ICER) of bariatric surgery versus no surgery. The ICER was calculated by dividing the incremental costs (difference in costs between surgery (RYBG or SG) group and non-surgery group) by incremental QALY (difference in QALYs between the two surgery and non-surgery groups).
The model was developed using Microsoft Excel 2010 Software [29] .
Sensitivity Analysis
In order to address parameter uncertainty we used both deterministic and probabilistic sensitivity analyses.
We conducted a series of one-way sensitivity analyses to test the robustness of the cost calculation and to determine how changes in certain parameters affected the total cost helping in revealing the key drivers of the cost-effectiveness.
In one-way sensitivity analyses, the ICERs were recalculated when individual parameters were varied, including the gain in quality of life per unit of BMI, the intervention costs, the initial weight and weight reduction after intervention and the discount rate. The one-way sensitivity analysis was performed on individual parameters over minimum and maximum ranges that were derived from UCLH data.
We also conducted probabilistic sensitivity analyses (PSA) [30] with 1,000 bootstraps replications to assess the robustness of our results to input parameters uncertainty around multiple parameters simultaneously. The analyses were performed with appropriate distributional assumptions for each variable parametrised related to the nature of the variable.
The PSA were based on a gamma distribution for intervention, medical costs and disutility scores, a beta distribution for the quality of life gain associated with BMI reduction, a lognormal distribution for post-surgical weight loss and obesity drift. The results of the PSA are summarised as the probability of each procedure being cost-effective at different willingnessto-pay (WTP) levels, or threshold for cost-effectiveness, using cost-effectiveness acceptability curves [31] . We also used the PSA to generate 95% confidence intervals around the point estimates based on the standard error of the values from the 1,000 bootstrap replications.
Results
Participants' Characteristics
Data from 18 adolescents who underwent bariatric surgery were analysed. Nine adolescents underwent RYBG and nine underwent SG. Mean age of adolescents at time of surgery who underwent RYGB was 17.8 years and of those who underwent SG it was 18.7 years. Mean BMI (standard deviation, SD) at baseline for those who underwent RYBG was 48.3kg/m 2 (SD 6.2) and for those who underwent SG it was 60.0 kg/m 2 (SD 9.3) ( Table 1) .
Base Case Analysis
The parameter values for the cost-effectiveness model and their ranges used in sensitivity analyses are presented in Table 2 . Table 3 ). The higher costs of surgery were due to the costs of the surgical procedure itself and the costs of pre-and post-operative care. These were offset by the costs of treating co-morbidities, which were slightly lower with surgery.
The incremental cost per QALY gained of RYGB versus no surgery was £2,018 (95% CI £1,942 to £2,042) for males and £2,005 (95% CI £1,974 to £2,031) for females. The mean incremental cost per QALY gained of SG versus no surgery was £1,978 (95% CI £1,954 to £2,002) for males and £1,941 (95% CI £1,915 to £1,969) for females (Table 3) .
Sensitivity Analysis
One-way sensitivity analyses were conducted for the most influential variables with the higher impact on the model's results. The results did not vary appreciably in the sensitivity analyses.
The incremental cost per QALY gained remained under £5,000 for bariatric surgery versus no surgery for both types of procedures when all the parameter values were varied within plausible limits (Table 4 and Online supplementary Table S1 and Table S2 ).Results of the probabilistic cost-effectiveness analysis are presented in Online Supplement- Table S3 . The costeffectiveness acceptability curves for bariatric surgery compared to no surgery indicate the probability of bariatric surgery being more cost-effective than the no surgery for a range of values a decision maker is willing to pay for an additional unit of health gain.
At NICE's recommended threshold of £20,000 per QALY gained [32], the probability of bariatric surgery being cost-effective is >90% (Figure 2 ).
Discussion
Our study shows that bariatric surgery in adolescents with severe obesity is highly costeffective over the long term and also improves quality-adjusted life years. Costs of surgery are significantly higher than for the non-surgical group; however the benefits of improved quality and length of life result in surgery being highly cost-effective. 
Strengths and weaknesses
We used an unselected cohort from the largest UK centre undertaking adolescent bariatric surgery, together with modelled data from nationally representative surveys and authoritative data sources. Our estimates of cost-effectiveness are likely to be conservative. We accounted for likely upward BMI drift after surgery using data taken from studies of obese adults after bariatric surgery, but did not include drift in the non-surgery group, although this is likely.
Quality of life estimates were taken from samples of morbidly obese adults. We included costs of follow-up after surgery up to 5 years, but did not include any follow-up costs for the nonsurgery group past 1 year. Obesity is recognised as being a risk factor for co-morbidities other than those included in the model (diabetes, CHD, stroke and colon cancer) and thus our model likely underestimates the impact of obesity. Together, these suggest that our findings likely underestimate the cost-effectiveness of surgery.
We undertook a long-term evaluation of bariatric surgery. Findings were further strengthened by sensitivity analyses showing that large change in cost or utility estimates did not change the main conclusions.
Our findings are subject to a number of limitations. The main limitation is that data on the impact of surgery on BMI was available for only 18 adolescents. While this number is small, it is the largest UK cohort at the time. Further research would be beneficial in future with a larger cohort of UK patients. Our model only captures the direct costs. Cost owing to loss of productivity caused by obesity and its co-morbidities were not included in the analysis. This is a conservative assumption as many of the costs associated with obesity may fall on individuals as well as society.
Also, medication costs were not incorporated in the model.
While we had a precise estimate of the costs of bariatric surgery at UCLH, the lack of empirical quality of life data from patients who underwent bariatric surgery could cause uncertainty in the model. Future evaluation is needed to measure and incorporate changes in quality of life from the adolescent population undergoing bariatric surgery.
Costs for procedures were provided by a single centre (UCLH), which has high costs due to being a central London teaching hospital. Costs shown here therefore may be higher than in other hospitals; however, this would lead to an underestimate of the cost-effectiveness of surgery. Further, our assumptions regarding post-operative resource use may be excessively high. Again, this suggests that the model provides a conservative estimate of the costeffectiveness of the bariatric surgery and potentially overestimates the overall impact of obesity.
Conclusions
Bariatric surgery of adolescents with severe obesity is a cost-effective alternative to no surgery from the perspective of the UK's NHS. around the mean (except discount rate values); RYGB = Roux en Y Gastric Bypass; SG = Sleeve Gastrectomy; CHD = coronary heart disease; BMI = body mass index. (Table 1 and Table 2 ) for detailed results for every scenario; BMI = body mass index QALY = quality adjusted life year; ICER = incremental cost-effectiveness ratio; BMI = body mass index
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